Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2008Nephron Clinical Practice

Nephrogenic Systemic Fibrosis: More Questions and Some Answers

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSameh K. MorcosChinese University of Hong KongHTHenrik S. ThomsenUniversity of Copenhagen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morcos et al. (2008) studied this question.

synapsesocial.com/papers/6a1d6ecf1024216094055b29https://doi.org/10.1159/000151228
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Case-control study of gadodiamide-related nephrogenic systemic fibrosis2007 · 204 citations
  2. 2Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass Spectroscopy2006 · 363 citations
  3. 3Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents2006 · 442 citations
  4. 4Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium2007 · 104 citations